[1] Siegel RL, Miller KD, Jemal A.Cancer statistics,2015[J]. CA Cancer J Clin, 2015, 65(1):5-29. [2] Sun SC.The noncanonical NF-κB pathway[J]. Immunol Rev, 2012, 246(1): 125-140. [3] Sun SC.Non-canonical NF-κB signaling pathway[J]. Cell Res, 2011, 21(1): 71-85. [4] Karin M, Cao Y, Greten FR, et al.NF-kappaB in cancer: from innocent bystander to major culprit[J]. Nat Rev Cancer, 2002, 2(4): 301-310. [5] 刘志,闫威,赵春清,等.血管内皮生长因子与细胞增殖核抗原在直肠癌组织中的表达及临床意义[J].中国综合临床,2014,30(11):1197-1199. [6] 修丽娟,孙大志,刘宁宁,等.幽门螺杆菌阳性胃癌组织中RUNX3、NF-κB p65蛋白表达及临床意义[J].中华临床医师杂志(电子版),2016,10(1):11-15. [7] 何焯成,林智文,林旭,等.乳腺癌组织AKIPl和P65的表达及其临床意义[J].岭南现代临床外科,2016,12(6):227-230. [8] 刘欢,杨桂芳.肝癌组织中P61、P21、P53及NF-κB P50的表达及临床意义[J].医学新知杂志,2015,25(3):171-173. [9] 郭晓红,谢英华.人乳头状瘤病毒感染与宫颈癌组织中核转录因子κB表达的关系研究[J].中华医院感染学杂志,2015, 25(19):4375-4378. [10] 韩佳滨,孟宪瑛,郑桂彬,等.核转录因子-κB与甲状腺癌的关系研究进展[J].中华内分泌外科杂,2014,8(1):74-76. [11] 季志刚,刘杰,毕崇尧.结肠癌组织AKIPl、PKA及P65的表达及意义[J].中国医药导报,2013,10(26):76-78. [12] Lessard L, Saad F, Le Page C, et al.NF-kappa B2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells[J]. Cell Signall, 2007, 19(5):1093-1100. [13] Cogswell PC, Guttridge DC, Funkhouser WK, et al.Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3[J]. Oncogene, 2000, 19(9):1123-1131. [14] Kang MR, Kim MS, Kim SS, et al.NF-κB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas[J]. Pathology, 2009,41(7): 622-625. [15] Dimitrakopoulos FI, Antonacopoulou AG, Kottorou A, et al.NSCLC and the alternative pathway of NF-κB: uncovering an unknown relation[J]. Virchows Archiv, 2012,460(5):515-523. |